Correlation Between Regeneron Pharmaceuticals and Lion One

Can any of the company-specific risk be diversified away by investing in both Regeneron Pharmaceuticals and Lion One at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Regeneron Pharmaceuticals and Lion One into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Regeneron Pharmaceuticals and Lion One Metals, you can compare the effects of market volatilities on Regeneron Pharmaceuticals and Lion One and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Regeneron Pharmaceuticals with a short position of Lion One. Check out your portfolio center. Please also check ongoing floating volatility patterns of Regeneron Pharmaceuticals and Lion One.

Diversification Opportunities for Regeneron Pharmaceuticals and Lion One

0.86

Correlation Coefficient

Regeneron Pharmaceuticals  Lion One

Very poor diversification

The 3 months correlation between Regeneron and Lion is 0.86. Overlapping area represents the amount of risk that can be diversified away by holding Regeneron Pharmaceuticals and Lion One Metals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lion One Metals and Regeneron Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Regeneron Pharmaceuticals are associated (or correlated) with Lion One. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lion One Metals has no effect on the direction of Regeneron Pharmaceuticals i.e., Regeneron Pharmaceuticals and Lion One go up and down completely randomly.

Pair Corralation between Regeneron Pharmaceuticals and Lion One

Given the investment horizon of 90 days Regeneron Pharmaceuticals is expected to under-perform the Lion One. But the stock apears to be less risky and, when comparing its historical volatility, Regeneron Pharmaceuticals is 2.49 times less risky than Lion One. The stock trades about -0.16 of its potential returns per unit of risk. The Lion One Metals is currently generating about 0.14 of returns per unit of risk over similar time horizon. If you would invest  19.00  in Lion One Metals on October 12, 2024 and sell it today you would earn a total of  2.00  from holding Lion One Metals or generate 10.53% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Strong
Accuracy	100.0%
Values	Daily Returns

Regeneron Pharmaceuticals  vs.  Lion One Metals

Regeneron Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Regeneron Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in February 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Lion One Metals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Lion One Metals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's essential indicators remain nearly stable which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Pair Trading with Regeneron Pharmaceuticals and Lion One

The main advantage of trading using opposite Regeneron Pharmaceuticals and Lion One positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Regeneron Pharmaceuticals position performs unexpectedly, Lion One can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lion One will offset losses from the drop in Lion One's long position.

The idea behind Regeneron Pharmaceuticals and Lion One Metals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.